Del Nido versus blood cardioplegia in cardiac surgery with prolonged aortic cross-clamp time: a meta-analysis
摘要
Research on the safety and efficacy of del Nido cardioplegia in complex adult cardiac surgeries with prolonged aortic cross-clamp times remains limited. This study aimed to compare early clinical outcomes between the use of del Nido and blood cardioplegia in this patient cohort.
MethodsA comprehensive database search was conducted using PubMed, Scopus, and the Cochrane Central Register of Controlled Trials through August 2024 to perform a meta-analysis comparing del Nido versus blood cardioplegia in adult cardiac surgery with prolonged aortic cross-clamp time (≥ 90 min). The primary endpoint was early mortality, and secondary endpoints included postoperative morbidity, left ventricular ejection fraction (LVEF), and cardiac enzymes. A random effects model was used to estimate the pooled effect size.
ResultsSix studies met our eligibility criteria, including three propensity score–matched studies, with a total of 1916 patients. The incidence of early mortality was comparable between the del Nido and control groups, with a pooled odds ratio of 1.25 (95% confidence interval: 0.90, 1.25; p = 0.147). The incidence of postoperative stroke (p = 0.137), renal failure (p = 0.796), and atrial fibrillation (p = 0.449); postoperative LVEF (p = 0.379), and highest creatine kinase-myocardial band level (p = 0.151) were also similar. Highest troponin T level was significantly lower in the del Nido group with a standardized mean difference of − 0.22 (− 0.44, − 0.00; p = 0.049).
ConclusionsIn adult cardiac surgery with prolonged aortic cross-clamp, del Nido cardioplegia provides comparable myocardial protection and early mortality and morbidity rates compared to conventional blood cardioplegic solutions.